Ng George K
Insider CIK 1638744 · KTRA Director · PCSA Chief Executive Officer, Director · SRNE See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-08-08 | 2026-08-11 | 1,600 | — | $0 | 19,624 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-08-08 | 2026-08-11 | 1,600 | — | $0 | 17,092 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-08-08 | 2026-08-11 | 1,600 | — | $0 | 19,624 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-08-08 | 2026-08-11 | 1,600 | — | — | 17,092 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 9,384 | — | $0 | 21,224 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 9,384 | — | $0 | 21,224 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-07-01 | 2026-07-01 | 3,057 | $1.93 | $5.9K | 15,492 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-06-15 | 2026-06-16 | 2,465 | $2.22 | $5.5K | 12,435 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-29 | 2026-06-01 | 2,129 | $2.57 | $5.5K | 9,970 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-15 | 2026-05-19 | 1,843 | $2.97 | $5.5K | 7,841 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-30 | 2026-05-01 | 2,034 | $2.69 | $5.5K | 6,013 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-15 | 2026-04-17 | 1,843 | $2.97 | $5.5K | 5,492 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-15 | 2026-04-30 | 1,843 | $2.97 | $5.5K | 3,979 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-15 | 2026-05-19 | 1,843 | $2.97 | $5.5K | 3,979 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-01 | 2,136 | $2.54 | $5.4K | 3,649 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-30 | 2,136 | $2.54 | $5.4K | 2,136 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2026-02-12 | 2026-02-17 | 156,240 | — | $0 | 156,240 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 768,000 | — | $0 | 768,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 256,000 | — | $0 | 256,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-07-24 | 2025-07-28 | 1,822,471 | — | $0 | 1,922,471 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 43,600 | — | $0 | 43,600 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 87,200 | — | $0 | 87,200 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2025-01-27 | 2025-01-29 | 87,200 | $0.80 | $69.8K | 87,200 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2025-01-02 | 2025-01-06 | 51,275 | — | $0 | 51,275 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-22 | 13,553 | — | $0 | 13,553 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-22 | 35,780 | — | $0 | 35,780 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-22 | 13,553 | — | $0 | 13,553 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2024-01-30 | 2024-01-31 | 10,000 | $2.70 | $27.0K | 20,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-12 | 2023-10-12 | 100,000 | $0.25 | $25.0K | 200,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-10 | 2023-10-10 | 100,000 | $0.25 | $25.0K | 100,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-08-08 | 2023-08-09 | 400,000 | — | $0 | 400,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-08-08 | 2023-08-09 | 400,000 | — | $0 | 800,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | J Other | 2018-02-28 | 2018-02-28 | 163,469 | — | $0 | 302,146 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2018-02-28 | 2018-02-28 | 90,000 | $9.95 | $895.5K | 101,453 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2017-09-14 | 2017-09-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | J Other | 2017-09-11 | 2017-09-15 | 89,339 | — | $0 | 138,677 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2017-02-03 | 2017-02-03 | 40,000 | $5.15 | $206.0K | 49,338 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award | 2016-11-08 | 2016-11-09 | 89,338 | — | $0 | 90,226 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2016-08-12 | 2016-08-16 | 100,000 | — | $0 | 260,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2016-03-11 | 2016-03-15 | 40,000 | — | $0 | 160,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2015-08-21 | 2015-08-21 | 500 | $13.49 | $6.7K | 500 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2015-08-21 | 2015-08-21 | 55 | $13.34 | $734 | 888 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2015-08-21 | 2015-08-21 | 333 | $13.55 | $4.5K | 833 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | P Buy | 2015-08-03 | 2015-08-05 | 11,453 | $11.50 | $131.7K | 14,901 | SEC↗ |